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accelerometry: is it useful?
Eivind Aadland1* and Jostein Steene-Johannessen2Abstract
Background: Variation in counts between subjects at a given speed or work rate are the most important source of
error in physical activity (PA) measurements with accelerometers. The aim of this study was to explore how the use
of individual accelerometer cut points (ICPs) affected the analysis of PA field data.
Methods: We performed a treadmill calibration protocol to determine cut points for moderate to vigorous PA
(MVPA) (≥3 metabolic equivalents) and assessed free-living PA in 44 severely obese subjects using the Actigraph
GT1M accelerometer. We obtained cut points in 42 subjects (11 men, mean (standard deviation) of body mass
index (BMI) 39.8 (5.7), age 43.2 (9.2) years), of whom 35 had valid measurement of free-living PA (minutes of MVPA/
day). Linear regression was used to analyze associations with the ICPs and time in MVPA/day. MVPA/day was also
compared with values derived using a group cut point (GCP).
Results: Resting oxygen consumption (partial r = 0.74, p < .001), work economy (partial r = −0.76, p < .001) and
BMI (partial r = 0.52, p = .001) explained 68.4% of the variation in the ICPs (F = 26.7, p < .001). The ICPs explained
79.1% of the variation in the minutes spent in MVPA/day. Moderate to vigorous PA/day derived from the ICPs vs.
the GCP varied substantially (R2 = 14%, p = .023, coefficient of variation = 45.1%).
Conclusions: The results indicate that the use of ICPs had a strong influence on the PA level. Two thirds of the
variation in the ICPs could be explained, however, a certain degree of measurement error will be present. Thus, we
are not able to conclude with respect to the most appropriate procedure for analyzing time in MVPA.
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Accelerometers have changed physical activity (PA)
reporting from a self-reported estimate of intensity and
duration to an objective measurement of bodily move-
ment. Movements are quantified based on changes in
accelerations and reported in the more or less arbitrary
unit “counts”. To become meaningful, counts may be
analyzed and interpreted in several different ways [1].
Because the health benefits of PA are determined, at
least in part, by the work rate of the activity [2], the time* Correspondence: eivind.aadland@hisf.no
1Sogn og Fjordane University College, Faculty of Health Studies, Box 523,
Førde 6803, Norway
Full list of author information is available at the end of the article
© 2012 Aadland and Steene-Johannessen; lice
terms of the Creative Commons Attribution L
use, distribution, and reproduction in any medspent at different work rates is one meaningful way to
report the data. Thus, it is essential to establish accelerom-
eter count cut points to separate sedentary behavior, light,
moderate and vigorous PA, currently recommended to be
defined as <1.5, 1.5-2.9, 3–5.9 and ≥6 metabolic equivalents
(METs), respectively [2-4].
Numerous makes and models of accelerometers are
currently in use to determine the PA level (e.g. Tritrac,
Actigraph, BioTrainer, ActiTrac, Actical, Tracmor,
Actiwatch, Sensewear, ActiHeart, ActiReg) [5-7]. In all
cases, measurement variability of both technical and bio-
logical origin will be present. Accordingly, variability can be
attributed to differences between devices (inter-instrument
variation), differences over time (intra-instrumentnsee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
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variation) and interactions between these different sources
of variation. Currently, most methodological research
concerning accelerometry has focused on calibrating
(validating) accelerometer output according to some
standard measure. However, because reliability is a
premise for validity [8], research exploring measurement
variability is important to reveal the different sources of
variation (reviews of reliability studies for accelerometer
measurement can be found elsewhere [5,9]). For instance,
Actigraph instruments (Actigraph, Fort Walton Beach,
FL, USA, formerly known as Computer Science and
Applications (CSA) and Manufacture Technology
Incorporated (MTI) models) are reported to have an
inter-instrument coefficient of variation (CV) of under 8.9%
[10-12] and an intra-instrument CV of under 4.4% [10,13].
The inter-instrument variation could be addressed through
an individual unit calibration. However, a study by Moeller
et al. [12] estimated that such a calibration explained
under 4.2% of the variation in field data for Actigraph
instruments. Hence, individual instrument calibration
may not be worth the effort.
A greater source of variability is the variation in
counts between subjects at a given speed or work rate.
Two studies have applied a design allowing three-way
analyses of variance between subjects, trials and instru-
ments [11,14]. Both studies concluded that variation
among subjects was by far the largest source of variabil-
ity in the measurements. According to Barnett & Cerin
[14], variation among subjects explained 89% of the total
variation in the measured counts during a field walk.
Welk et al. [11] reported that 63.4% of the variation in
the counts during a treadmill walking trial could be
ascribed to subject variation, whereas the remaining
variation was explained to a greater or lesser extent by
the interactions of trials and monitors with subjects.
Hence, a calibration to individual subjects may be more
important than the calibration of individual instruments.
A procedure of this type is also recommended in the
literature. This procedure is especially recommended for
intervention studies because they require precise
measurements at multiple time points [5,14,15].
We performed a treadmill calibration study of the
Actigraph GT1M in 44 young to middle-aged severely
obese subjects because cut points for use in this population
is lacking and the equations for determining cut points may
be population-specific [16]. The metabolic cost of walking
increases with age and body weight [17-19], and this is not
captured by an accelerometer [20,21]. The aim of the study
was to explore how individual cut points (ICPs) for
moderate to vigorous PA (MVPA) (≥3 METs) affected
the assessment of free-living time spent in MVPA in
severely obese subjects. We hypothesized that there would
be no relationship between the ICPs and PA level.Methods
Subjects
Forty-nine severely obese patients were enrolled at the
Red Cross Haugland Rehabilitation Center in Norway
between February 2010 and February 2011 to begin a
lifestyle treatment program for obesity. The inclusion
criteria for participation included an age between 18 and
60 years and a body mass index (BMI) > 40 kg/m2 with-
out comorbidities, or a BMI > 35 with comorbidities.
The exclusion criteria included pregnancy, heart disease,
drug or alcohol abuse, previous bariatric surgery, and
mental disorders and physical impairments that could
reduce the subject’s ability to comply with the program.
Written informed consent was obtained from each
subject prior to inclusion in the study. This study met
the standards of the Declaration of Helsinki and was




The lifestyle treatment program was an intermittent in-
patient program, and the first stay lasted six weeks. The
PA level assessed by accelerometry was measured over a
seven-day period about one month prior to the start of
the lifestyle treatment program. Maximal oxygen
consumption (VO2max) was measured in the first week,
and the subjects who had little experience walking on a
treadmill were advised to practice treadmill walking
before the calibration study was performed. The calibra-
tion study was performed during the fourth week of the
stay. The subjects visited the lab after a minimum of one
hour of fasting and were not permitted to perform
intense PA prior to the testing. They were weighed to
the nearest 0.1 kg (BC 420 S MA, Tanita Corp, Tokyo,
Japan) and were equipped with a heart rate monitor
chest belt (Polar Electro Oy, Kempele, Finland) and an
Actigraph GT1M accelerometer (Actigraph, Fort Walton
Beach, FL, USA). Technical specifications of the acceler-
ometer can be found elsewhere [22]. All the subjects
wore an accelerometer attached in the mid axillary line
of the right hip at the height of the umbilicus. Thirty
different instruments were used in this case. In addition,
22 of the subjects wore an accelerometer at the left hip.
In this case, the same instrument was used for every
subject. The accelerometers were set at a 10-second
epoch and a normal filtering option.
Treadmill calibration protocol and analysis
The test protocol consisted of two parts. First, the
subjects were rested in a sitting position for 10 minutes
to measure their resting oxygen consumption (resting
VO2) according to the originally proposed definition of 1
MET [23]. Then, the subjects walked on the treadmill
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km/h. Multiple treadmill speeds were checked manually
to validate the treadmill speed. Oxygen consumption for
the last seven minutes at rest and the last four minutes
at each speed on the treadmill was measured using the
Metamax I and the Metasoft v. 1.11.05 software (Cortex
Biophysic, Leipzig, Germany). A one-point gas calibration
using ambient air and a volume calibration using a three-
liter syringe (SensorMedics Corporation, CA, USA) were
performed between each test. The Metamax 1 analyzer has
been shown to have no systematic error and a random
error of 4% compared to the Douglas bag technique [24].
The last two minutes at rest and the last two minutes
at each treadmill speed were used to calculate the
oxygen consumption and accelerometer counts. Both
measurements were originally reported for 10-second
periods and were summed to determine the mean values
of the oxygen consumption/min and counts/min. The
counts/min was calculated from the vertical axis using
the comma separated values (CSV)-files exported from
the ActiLife v.5.3 software (Actigraph, Fort Walton
Beach, FL, USA). The oxygen consumption from walking
was divided by the oxygen consumption at rest to
express the values for the metabolic cost of walking as
individually adjusted MET-values.
Measurement and analysis of PA
Subjects were instructed to wear the accelerometer at all
times, except during water activities (swimming, showering)
or while sleeping. All files were analyzed using the ActiLife
v. 5.3 software. A wear-time of ≥ 10 hours/day for ≥ five
days was used as the criterion for a valid measure. Periods
of ≥ 60 minutes (allowing for ≤ 2 minutes of non-zero
counts) were defined as non-wear time [9,25]. The PA level
was reported as minutes of MVPA/day and time in bouts
of MVPA/day. The time spent in bouts of MVPA was
defined as consecutive time in MVPA of ≥ 10 min in
duration, allowing for ≤ 2 minutes drop below the cut
point.
Statistical analyses
The individual cut points were obtained from ordinary
linear regression. Each dataset was checked with a
scatterplot, and the Pearson (r) correlation and standard
error of the estimate (SEE) was calculated. Despite a
quadratic fit was indicated in some individuals, this was
omitted because we believe a linear fit would be more
robust on the individual level having only five observations.
For two subjects, the MVPA cut points were estimated to
have negative values. These cut points were replaced with
cut point values of 100 counts/min.
To compare the cut points obtained from the right
and the left hip, we used a Bland-Altman plot showing
the differences between the hips (left hip – right hip) asa function of the mean value of the two variables [26].
Because the data were deemed to be homoscedastic, the
standard error of the measurement (SEM) and the limits
of agreement (LoA) were calculated according to Hopkins
[27] (SEM = standard deviation (SD) of the differences /
√2; LoA = SEM * √2 * 1.96). A one-sample Wilcoxon test
was used to test the mean differences between the oppos-
ite hips. The Spearman correlation coefficient (ρ) and CV
(SD/mean) was used to compare MVPA derived from
ICPs and the GCP because the data were deemed to be
heteroscedastic.
A linear regression model was used to explore the
relationships between the ICPs (dependent variable) and
age, sex, body mass index (BMI), height, resting VO2
(ml/kg/min) and work economy (VO2 (ml/kg/min) at
three km/h (independent variables). A quadratic regres-
sion model (i.e., including the second order term of
ICPs) was used to determine the relationship between
the ICPs and minutes of MVPA/day and minutes in
bouts of MVPA/day (inclusion of a third order term did
not improve the models), whereas only the first order
term was used in the model for total PA level (counts/
min) (inclusion of the second order term did not im-
prove the model). The effect of the ICPs versus potential
confounding variables on PA level were determined by
1) including the same independent variables as above
(age, sex, BMI, height, resting VO2 (ml/kg/min) and
work economy (VO2 (ml/kg/min) at three km/h)) in the
model having PA level as the dependent variable and 2) the
same model were repeated with inclusion of the first and
second order term of the ICPs. Effects are reported as par-
tial correlations (partial r).
A group cut point (GCP) was derived using a linear
mixed model regression based on restricted maximum
likelihood estimation. Subjects were given a random
intercept and treadmill speed was defined as a repeated
measure using an autoregressive (AR1) covariance
structure. No other random effects were included. This
yielded a cut point of 685 counts/min based on the
following model: METs = 2.5276 + 0.000690*counts/min
(CI for intercept 2.2456 to 2.8096, F = 319.3, p <.001; CI
for slope 0.000626 to 0.000753, F = 470.0, p < .001).
Although we found a significant effect of the quadratic
term counts/min2, this was omitted for the purpose
of comparison with the ICPs. Residuals were normally
distributed. Median differences between time in
MVPA/day and time in bouts of MVPA/day analysed
using the GCP and the ICPs were tested using the
Wilcoxon’s signed rank test for dependent samples.
The relationships between the measures were tested
using the Spearman's ρ.
The main analyses were performed using SPSS v. 19.0
(SPSS Inc., Chicago, USA). P < 0.05 indicated significant
differences.
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A total of 49 subjects were recruited to the lifestyle
intervention program. Of these, 44 subjects performed
the treadmill calibration procedure. After two subjects
were excluded owing to accelerometer malfunction, 42
subjects (11 men) had valid accelerometer calibration
data. The characteristics of the subjects are shown in
Table 1. A total of 40 subjects had a valid free-living PA
accelerometer-measurement. Thirty-five subjects had
both valid calibration data and free-living PA data.
Consequently, the analysis of the ICPs applied to the
field data and the comparison of the field data results
using the GCP and the ICPs was based on 35 subjects.
In addition, 22 subjects wore an accelerometer on the
left hip. Accordingly, the comparative analysis of the
accelerometer data from opposite hips was based on 22
subjects.
The individual regression lines for the measurement at
the right hip are shown in Figure 1 and mean (SD) of
the ICPs for the group is shown in Table 1. The medians of
the individual correlation coefficients between counts/min
and the MET-values were r = 0.98 and r = 0.97 for the right
and the left accelerometer, respectively. The corresponding
SEEs were 0.29 and 0.34 METs.
The walking speeds at three METs are shown in Figure 2.
Minimum and maximum values were 1.1 and 3.5 km/h,
respectively.
Substantial differences were found between the
counts/min measured at the right hip and at the left hip,
with SEM and LoA values of 363 and 1007 counts/min,
respectively. Figure 3 shows the Bland-Altman plot of
the differences between the cut points calculated from
the right and the left accelerometer. The mean ICP were




Height (cm) 172.2 (9.1)
Weight (kg) 118.2 (18.2)
BMI (kg/m2) 39.8 (5.7)
WC (cm) 127.6 (13.2)
VO2max (l/min) 3.29 (0.66) (n = 32)
VO2max (ml/kg/min) 27.61 (5.19) (n = 32)
PA level (counts/min) 167.6 (64.8) (n = 40)
ICP 1151 (685)
Resting VO2 (l/min) 0.36 (0.07)
Resting VO2 (ml/kg/min) 3.04 (0.40)
Walking speed at 3 METs (km/h) 2.60 (0.57)
Mean (SD). BMI = body mass index, WC = waist circumference, VO2max = maximal o
point; Resting VO2 = resting oxygen consumption; METs = metabolic equivalents.counts/min for the right hip and the left hip, respectively;
difference (median, IQR) 7.4, 213.0 counts/min, p = .910).
However, the individual differences were substantial, with
a SEM of 288 counts/min and a LoA of 798 counts/min
(95% LoA for the cut points at the left hip were −790.6
to +805.4 compared to the right hip).
Resting VO2 (partial r = 0.74, p < .001), work economy
(partial r = −0.76, p < .001) and BMI (partial r = 0.52,
p = .001) explained 68.4% of the variation in the ICPs
(F = 26.7, p < .001). Resting VO2 (partial r = 0.98, p < .001)
and work economy (partial r = −0.97, p < .001) explained
97.1% of the variation in treadmill walking speed at three
METs (F = 647.0, p < .001).
Figure 4 shows the relationship between the ICPs and
the minutes of MVPA/day. The ICPs alone explained
79.1% of the variance in the total minutes of MVPA/day
(R2 = 0.791, F = 62.4, p < .001) and 62.5% of the variance
in the minutes in bouts of MVPA/day (R2 = 0.625, F = 27.5,
p < .001).
Resting VO2 (partial r = −0.50, p = .002), work econ-
omy (partial r = 0.55, p = .001) and age (partial r = 0.44,
p = .009) explained 58.5% of the variation in the minutes
of MVPA/day (F = 15.0, p < .001). When the ICPs were
included in the model, only the first (partial r = −0.67,
p < .001) and the second order term (partial r = 0.57,
p < .001) of the ICPs were significant predictors for minutes
of MVPA/day (resting VO2, work economy and age: partial
r = 0.00 to 0.19, p = .296 to .983) (R2 = 0.803, F = 24.4,
p < .001 for model). The results were very similar when
bouts of MVPA were used as the dependent variable:
Resting VO2 (partial r = −0.42, p = .013), work economy
(partial r = 0.45, p = .008) and age (partial r = 0.49,
p = .004) explained 53.5% of the variation (F = 12.3,
p < .001), while only the ICPs were significant predictorsMen Women
11 31
42.1 (8.5) 43.6 (9.5)
182.3 (8.0) 168.6 (6.4)
127.1 (16.0) 115.1 (18.0)
38.3 (4.9) 40.4 (6.0)
131.8 (11.3) 126.1 (13.7)
4.16 (0.60) (n = 8) 3.00 (0.37) (n = 24)
32.30 (5.41) (n = 8) 26.05 (4.15) (n = 24)
146.4 (68.4) (n = 10) 174.7 (63.1) (n = 30)
1335 (720) 1087 (673)
0.42 (0.09) 0.34 (0.05)
3.26 (0.43) 2.96 (0.36)
3.00 (0.37) 2.47 (0.58)
xygen consumption, PA level = physical activity level; ICP = individual cut
Figure 1 Individual regression lines of counts/min vs. individual
MET-values for 42 severely obese subjects. Subjects walked on a
treadmill at 2, 3, 4, 5 and 6 km/h.
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and age: partial r = −0.05 to 0.32, p = .073 to .803)
(R2 = 0.668, F = 12.0, p < .001 for model). The ICPs was
not related to total PA level (counts/min) in the bivariate
model (R2 < 0.01, F = 0.1, p = .758) or in the multivariateFigure 2 Histogram showing the distribution of treadmill
walking speeds at three METs.model (partial r = 0.09, p = .636), nor was any other of the
six independent variables used (partial r = −0.23 to 0.18,
p = .228 to .983) (R2 = 0.13, F = 0.8, p = .783 for model).
On a group level, applying ICPs or a GCP yielded
similar results for time in MVPA/day ((median (IQR)
60.1 (84.0) vs. 86.5 (35.3) min, respectively, p = .107)
and bouts of MVPA/day (21.5 (45) vs. 29.7 (29.3) min,
respectively, p = .272). The relationships between the
measures were low to moderate (time in MVPA/day:
ρ = 0.38, p = .023, CV = 45.1%; time in bouts of MVPA/
day: ρ = 0.58, p < .001, CV = 51.2%).
Discussion
The principal finding of this study was that the use of
ICPs to determine the minutes of MVPA/day measured
by accelerometry influenced the PA output substantially.
Thus, minutes of MVPA determined by ICPs and a GCP
varied considerably, indicated by low to moderate corre-
lations and CVs of about 50% between the measures.
This means that the use of ICPs will lead to quite different
results on an individual level compared to using a common
cut point on a group level. However, it is difficult to
conclude with respect to the most appropriate procedure
for analyzing time in MVPA.
The finding of a strong association between the ICPs
and the measured minutes of MVPA/day was unex-
pected, as this indicates that subjects having lower ICPs
were more physically active than subjects having higher
ICPs. However, as we showed that two thirds of the
variation in ICPs are due to resting VO2, work economy
and BMI, most of the variation can be claimed to be true
(although measurement error will be present). Since
ICPs also attenuated the effects of all other independent
variables used to explain the minutes of MVPA, one can
argue that we managed to successfully determine ICPs
that accounted for sources of variation that influenced
work rate and thereby PA level. Thus, we can conclude
that the use of ICPs in the present study increased the
precision of the PA measurement. However, we will
point out two main challenges when drawing this con-
clusion. First, one third of the variation in the ICPs was
unexplained. Differences in gait patterns (beyond work
economy), accelerometer-units worn, the attachment
and tilt of the instruments are factors likely to explain
this variation. The finding of a relatively large SEM/LoA
for cut points obtained from the right and left hips, may
support this notion (although these differences also
could be attributed to biomechanical variations between
the dominant and non-dominant side of the body). The
attachment of the accelerometer may be a crucial aspect
of the precision of the measurement process because
tilting of the accelerometer or small differences in hip-
placement are known to influence the accelerometer
output [10,28]. We expected that the cut points derived
Figure 3 Bland-Altman plot of cut points obtained from the right vs. the left hip. Dotted lines are 95% limits of agreement.
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typical deviations would be under 8.9% [10-12]. Because
our data were homoscedastic, such a percentage difference
is difficult to evaluate. However, the SEM amounted to
approximately 27% of the group mean cut point. This result
shows that the uncertainty in defining ICPs is substantial
and that the percentage variation is greatest at the lower
end. Further, because a regression toward the mean effectFigure 4 Scatterplot showing the bivariate association between indiv
(p<.001).tended to be supported by the study data (i.e. subjects
having high or low cut points from the right accelerometer
had less extreme cut points from the left accelerometer),
the established ICPs probably shouldn’t be viewed as “true”
ICPs. It should be mentioned that the placement of the
accelerometers probably would be less standardized in a
field setting, compared to our laboratory setting, which
would introduce even greater errors in the PA field dataidual cut points and minutes of MVPA/day. Quadratic R2 = 0.791
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and influence the analyses of PA level. Our results revealed
that use of ICPs to explain minutes of MVPA increased the
explained variance with 10 – 20%, compared to the use of
resting VO2, work economy and age as independent
variables. This could imply that a certain degree of
measurement error influence the results. Furthermore,
measurement error in determining VO2 at rest and tread-
mill walking will add to this measurement error. Finally,
any deviations in gait pattern and work economy between
the treadmill walking and field will disturb the findings.
Second, if we believe that individual calibrations
increase the measurement precision, we have to accept
that use of a GCP may be more or less useless to deter-
mine minutes of MVPA on an individual level, as typical
deviations is about 50% and shared variance is only 14%
for total minutes of MVPA/day derived from ICPs vs.
GCP. These differences are caused by great diversity in
treadmill walking speed at three METs, which is accounted
for by applying the ICPs. However, for describing PA level
on a group level, applying ICPs or a GCP may lead to quite
similar results, although we recognize that the PA levels
derived from the GCP were about 40% higher than the PA
level derived from the ICPs (because the estimated cut
point from the regression model were somewhat lower
than the mean of the ICPs) and that our study may suffer
from lack of statistical power to detect a significant
difference.
The present results suggest that severely obese indivi-
duals achieve a moderate work rate at very different walk-
ing speeds (between 1.1 and 3.5 km/h). Thus, because all
movement detected above each individual’s walking speed
threshold is interpreted as MVPA, it is not surprising that
we found a strong association between ICPs and PA level.
As stated above, the use of ICPs may significantly alter
research findings compared to applying a GCP. Here we
will consider three relevant areas. First, an interesting
discussion is whether the use of ICPs can increase our
ability to detect relationships between PA and diverse
health outcomes. However, at this point we have no
evidence-based suggestion for how different outcomes
would be affected. Nevertheless, the difference between
ICPs and GCP would probably be greater in cross-sectional
analysis compared to experimental studies were the same
cut point is applied repeatedly on an intra-individual
level. Second, the use of ICPs vs. a GCP could influence
whether subjects are found to achieve PA guidelines or
not. In the present study we found a significant degree of
re-classification between application of ICPs vs. the GCP
(70% agreement, Kappa coefficient = 0.40, p = .299, result
not shown) in the analyses of whether subjects achieved ≥
30 min in bouts of > MVPA/day or not. Third, work rate
can be determined absolutely (oxygen consumption or
standardized MET-values etc.) or relative to an individual’smaximal work capacity (percentage of VO2max, etc.). This
may challenge exercise prescription for subjects having low
fitness levels, as “moderate” intensity exercise in absolute
terms, can actually be quite demanding [29]. We could
hypothesize that if resting metabolic rate, work economy
and/or BMI (which determined the ICPs) was related to
VO2max, applying ICPs could possibly relate better to each
individual’s maximal capacity than a common GCP. How-
ever, we did not find any statistically significant relationship
between ICPs and VO2max (ml/kg/min) (r = 0.17, p = .320,
result not shown).
Strengths and weaknesses
The main strength of the present study is the use of precise
and sophisticated measurements of the metabolic cost of
walking and free-living PA. Moreover, the study gives an
overview of the measurement properties of accelerometers
and the use of individual cut points. Finally, the inclusion of
a relatively large sample of subjects ensures the validity of
our results.
This study has several limitations. The main limitation
is that we do not have a valid criterion measure of minutes
of MVPA/day, meaning that a direct comparison of the
precision of a GCP vs. the ICPs could not be established.
Because there is no “gold standard” for the measurement of
time in various PA intensities, the criterion validity for the
accelerometer measurements is impossible to establish
[30,31]. Although PA measurements by accelerometry are
found to be moderately correlated with measurements
made using doubly labeled water [32], this technique is not
suitable to measure minutes of PA at different work rates,
as doubly labeled water only measure the total energy ex-
penditure over a given time period [30,31]. Therefore, it is
very difficult to perform a valid comparison of precision be-
tween the GCP and the ICPs. However, we established the
relative validity using the short-form of the International
Physical Activity Questionnaire (IPAQ) [33] (results not
shown). The minutes spent in bouts of MVPA/day were
moderately correlated with the IPAQ for both the GCP
(Spearman’s ρ = 0.64, p = .001) and the ICPs (ρ = 0.51,
p = .014) (n = 23). Because neither measure showed to
be superior in comparison with the other, the finding
does not encourage the use of one measure over another.
However, it is very well known that objective and subjective
PA outcomes are only moderately associated and that large
variation are found between studies (mean correlation
r = 0.37 (minimum r = −0.71 and maximum r = 0.98)
based on 148 studies) [34]. Therefore, we believe our
approach to the evaluation of applying ICPs should be
viewed as a meaningful way to answer the research
question asked.
Second, our results may not be valid in a normal-
weight population. As observed in the laboratory, the at-
tachment of the accelerometers can be more challenging
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jects, and tilting of the instrument is known to reduce the
level of counts [10]. In addition, musculoskeletal disor-
ders and other factors that might interfere with walking
capacity and work economy is much more common in se-
verely obese subjects, compared to less obese and normal-
weight subjects [35]. These effects may have produced
greater variability in this population than would have been
found in other populations. Thus, further research should
verify or falsify our findings in a sample of less obese
subjects.
Third, some issues regarding the performance of the cali-
bration protocol and calculation of the ICPs deserve a com-
ment. First, although we started the calibration procedure
at a low speed to account for the high metabolic cost of
walking in this group of severely obese subjects, 14 subjects
spend more than three METs at two km/h. The extrapola-
tion of the accelerometer counts to three METs may have
caused some uncertainty in the count thresholds in these
subjects. However, most subjects spent close to three METs
at two km/h (n = 7 < 3.20; n = 11 < 3.50 METs). In
addition, despite a quadratic fit between counts and
metabolic cost was indicated in some individuals, we
used linear models to derive ICPs to avoid overfitting
of the models based on only five observations. This
could have caused some uncertainty. However, applying
ICPs derived from quadratic models did not change any
findings. Second, we calibrated the accelerometers using
a treadmill protocol, while PA was measured in a field
setting. Although it doesn’t seem to be any agreement
on which setting that causes the highest cut points
(treadmill vs. track) [36,37], this may have caused vari-
ability on an individual level. Third, the participants
started a lifestyle treatment program for their obesity
in the period between performing the field measure-
ment and the calibration protocol (i.e. one month prior
to performing the calibration). This delay could have
added variability to the results, as changes in physical
fitness, resting metabolic rate or work efficiency could
influence the relationship between accelerometer
counts and work rate. Forth, the scaling of work rate to
each individual subject’s resting metabolic rate to ob-
tain individual MET-values, may have introduced a
systematic bias relating to body size, as body compos-
ition is the most important determinant of the resting
metabolic rate [38]. However, reanalysis of the data
using a standardized MET value (3.5 ml/kg/min) as the
reference for the calculation of work rate did not
change any main findings. Fifth, as minutes of MVPA
could be expected to increase with increased wear
time, wear time could influence the findings. However,
minutes of MVPA and percentage time in MVPA were
very highly correlated (r = 0.98) and the use of percent-
age time in MVPA did not change any findings.Conclusions
We have shown that individual calibration of acceler-
ometers based on a simple linear standard walking calibra-
tion approach performed at 2, 3, 4, 5 and 6 km/h influence
the minutes of free-living MVPA to a great extent. Further-
more, we observed great diversity in time spent in MVPA
when comparing the use of ICPs and a GCP to analyze PA
level. It could therefore be argued that applying ICPs
increase the measurement precision, but it is still difficult
to draw a final conclusion. Moreover, the impact of using
ICPs would probably depend on the research question
being posed. If one should interpret with a conclusion that
ICPs increase the measurement precision, one must also
accept that a GCP applied on individual data are more or
less useless to separate light PA from moderate-to-vigorous
PA. We believe that there is an urgent need for further
research that should explore the effect of applying ICPs
versus a GCP to measure minutes of MVPA in less obese
populations, as the use of ICPs may have the potential to
increase measurement precision.
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